Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis

被引:0
作者
George Dranitsaris
Carlo DeAngelis
Blake Pearson
Laura McDermott
Bernd Pohlmann-Eden
机构
[1] Augmentium Pharma Consulting Inc.,Leslie Dan Faculty of Pharmacy
[2] Odette Cancer Centre,Opioid Reduction Strategy, Local Health Integration Network
[3] University of Toronto,undefined
[4] Erie St. Clair,undefined
[5] Scientus Pharma Inc.,undefined
来源
Applied Health Economics and Health Policy | 2021年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:537 / 544
页数:7
相关论文
共 73 条
[1]  
Fischer B(2014)Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005–2011 Drug Alcohol Rev 33 19-26
[2]  
Jones W(2013)High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005–2009 Pharmacoepidemiol Drug Saf 22 438-442
[3]  
Urbanoski K(2020)The opioid mortality epidemic in North America: do we understand the supply side dynamics of this unprecedented crisis? Subst Abuse Treat Prev Policy 15 14-1043
[4]  
Skinner R(2016)The effect of medicinal cannabis on pain and quality-of-life outcomes in chronic pain: a prospective open-label study Clin J Pain 32 1036-198
[5]  
Rehm J(2015)Use of medical cannabis reduces pain and improves quality of life in cancer patients J Clin Oncol 33 198-50
[6]  
Fischer B(2018)Epidemiological characteristics, safety and efficacy of medical cannabis in the elderly Eur J Intern Med 49 44-1236
[7]  
Jones W(2017)Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study PLoS One 12 e0187795-E623
[8]  
Rehm J(2016)Medical marijuana laws reduce prescription medication use In Medicare Part D Health Aff 35 1230-687
[9]  
Fischer B(2019)Income-related disparities in private prescription drug coverage in Canada CMAJ Open 7 E618-701
[10]  
Pang M(2001)Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing J Pain Symptom Manage 22 672-355